CPB
37
-2
GD
52
3
GS
49
3
EOG
42
3
MAR
32
2
DE
59
6
HON
57
3
HAS
48
3
JCI
55
11
APD
40
-2
BDX
50
-2
BWA
41
-3
JNJ
39
-15
LB
48
4
AN
35
2
GPC
45
-2
IP
56
2
L
58
2
A
40
-4
AAP
32
-3
CPB
37
-2
GD
52
3
GS
49
3
EOG
42
3
MAR
32
2
DE
59
6
HON
57
3
HAS
48
3
JCI
55
11
APD
40
-2
BDX
50
-2
BWA
41
-3
JNJ
39
-15
LB
48
4
AN
35
2
GPC
45
-2
IP
56
2
L
58
2
A
40
-4
AAP
32
-3
Financhill
Back

iShares US Pharmaceuticals ETF Stock Predictions

Meet the founder that's revolutionizing smartphones

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

IHE
iShares US Pharmaceuticals ETF

Last Price:
$67.62
Seasonality Move:
4.39%

7 Day Trial

ALL ACCESS PASS

$ 7

AI Is Disrupting Marketing—Invest Before April 10!

⏳ Secure Your Stake in AI Marketing Before This Window Closes!

iShares US Pharmaceuticals ETF Stock Forecast

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 9.5% based on the past 18 years of stock performance.
  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
  • Is iShares US Pharmaceuticals ETF Stock Undervalued?
    The current iShares US Pharmaceuticals ETF [IHE] share price is $67.64. The Score for IHE is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.
  • IHE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will iShares US Pharmaceuticals ETF Stock Go Up Next Year?

  • Over the next 52 weeks, iShares US Pharmaceuticals ETF has on average historically risen by 9.5% based on the past 18 years of stock performance.

iShares US Pharmaceuticals ETF Stock Rating

Sell
38
iShares US Pharmaceuticals ETF (IHE) is a Sell

Is iShares US Pharmaceuticals ETF overpriced?

  • iShares US Pharmaceuticals ETF has risen higher in 12 of those 18 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%

iShares US Pharmaceuticals ETF Stock Price History

Is IHE stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IHE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NYSEARCA
Country:
United States
Industry:
Sector:
Type:
etf
Website:

52-Week Data

52-Week High:
73.28
52-Week Low:
62.68

Prediction Charts

Market Cap:
0
Price in USD:
67.64
Volume:
74.8K
Beta:
0.70

Technical Analysis

SMA50:
70.10
SMA100:
68.78
SMA200:
69.15
52-Wk Change:
0.79%

Stock Predictions

  • Is iShares US Pharmaceuticals ETF stock public?
    Yes, iShares US Pharmaceuticals ETF is a publicly traded company.
  • What is the iShares US Pharmaceuticals ETF stock quote today?
    The iShares US Pharmaceuticals ETF stock price is 67.64 USD today.
  • How to buy iShares US Pharmaceuticals ETF stock online?
    You can buy iShares US Pharmaceuticals ETF shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Mar-13 69.51 68.93 69.63 68.91
Mar-14 69.09 69.32 69.39 68.98
Mar-17 69.32 70.15 70.37 69.32
Mar-18 69.94 70.01 70.16 69.66
Mar-19 70.02 70.25 70.41 69.90
Mar-20 70.24 70.39 70.64 70.11
Mar-21 70.26 70.21 70.52 70.04
Mar-24 70.46 70.94 70.99 70.46
Mar-25 71.22 69.58 71.22 69.44
Mar-26 69.24 68.76 69.51 68.76
Mar-27 68.73 68.78 69.08 68.56
Mar-28 68.79 68.56 68.85 68.38
Mar-31 68.96 70.56 70.81 68.87
Apr-1 69.80 67.64 69.80 67.60

iShares US Pharmaceuticals ETF Earnings

Data Unavailable

iShares US Pharmaceuticals ETF Forecast Revenue Growth

Data Unavailable

* iShares US Pharmaceuticals ETF stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.